SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pluristem Therapeutics
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
295 17 0 PSTI
Emcee:  FJB Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
270Pluristem's Preclinical Results for Its PLX-RAD Cells Published in the Journxcentral1-7/9/2013
269Pluristem Provides Update on Clinical Status of IC Trials HAIFA, Israel, Jun 1xcentral1-7/9/2013
268Preclinical publication on PLX-RAD treatment for radiation: plosone.orgidos-6/20/2013
267Pluristem to Receive Clinical-hold notice from the U.S. FDA maya.tase.co.ilidos-6/4/2013
266Pluristem Welcomes Parliamentary State Secretary of the German Federal Ministry xcentral1-5/30/2013
265Pluristem to Present at FDA Symposium HAIFA, Israel, May 29, 2013 (GLOBE NEWSWxcentral115/30/2013
264Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia xcentral115/15/2013
263Pluristem Carving Out Distinct Niche in Orthopedic Medicine With New Clinical Trxcentral115/15/2013
262SOURCE: BioMedReports [graphic] May 08, 2013 07:01 ET Pluristem Carving Out DiFJB-5/8/2013
261Pluristem Develops PLX-RAD Cells for Use in Hematology Enhancing Hematopoietic xcentral1-5/7/2013
260Excerpt: Surely United, like any pharma partner, recognizes the simplicity of hFJB-4/30/2013
259Third Party Research Study Demonstrates Pluristem's PLX-PAD Cells' Safetxcentral124/29/2013
258Pluristem Expands PLX Product Portfolio in Orthopedics and Sports Medicine Pluxcentral1-4/23/2013
2573:19AM Pluristem Therapeutics: United Therapeutics receives regulatory approval FJB14/11/2013
256Pipeline Progress at Pluristem - Analyst Blog By Zacks.com, March 25, 2013, 0FJB-3/26/2013
255HAIFA, Israel, March 20, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. ( FJB13/20/2013
254Another clinical score for Pluristem Therapeutics (NASDAQ: PSTI) with the FDAFJB12/27/2013
253UTHR moves to phase I maya.tase.co.ilidos12/26/2013
252Pluristem Receives FDA Orphan Drug Status Designation for Treatment of Aplastic idos22/21/2013
251Industry Executives to Address Whether Stem Cell Therapies Can Turn the Traditioxcentral112/18/2013
250Pluristem Takes Possession of and Moving Into New State-of-the-Art Manufacturingxcentral1-1/30/2013
249Pluristem Updates Cell Manufacturing Industry on Its Proprietary 3D Cell Expansixcentral1-1/23/2013
248Pluristem Receives Approval to Expand Its Phase II Clinical Trial in Intermittenxcentral121/15/2013
247Pluristem's CEO Letter to Shareholders Dear Pluristem Shareholders, In 2xcentral121/7/2013
246Pluristem Initiates Final Validation of New Manufacturing Facility Capacity Desxcentral1112/27/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News